Dr. Scheim is a social epidemiologist interested in understanding (and ultimately, transforming) the impacts of social, policy, and healthcare environments on the health of stigmatized populations. He conducts community-engaged research with LGBT populations and people who use drugs, as well as methodological research on measuring intersectional social positions and experiences of discrimination.
Currently, Dr. Scheim leads community-based participatory research surveys with transgender populations in India and Canada funded by the National Institutes of Health and the Canadian Institutes of Health Research. He is also PI of an NIH-funded study to cognitively and psychometrically evaluate intersectional discrimination measures in English and Spanish. Dr. Scheim holds adjunct appointments in the Centre on Drug Policy Evaluation at St. Michael’s Hospital (Toronto, Canada) and in the Department of Epidemiology and Biostatistics at Western University (London, Canada).
Dr. Scheim received a PhD in Epidemiology and Biostatistics (2017) from Western University in Canada where he was a Pierre Elliott Trudeau Foundation and Vanier Canada Graduate Scholar, and completed postdoctoral training at the University of California, San Diego as a Canadian Institutes of Health Research Fellow.